Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells
Jin Zhou(Shanghai Jiao Tong University), Feng Luo(The University of Queensland), Li Fang(Hunan Cancer Hospital), Zhixi Li, Xiang Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), LU Li(Sichuan University), Hua Xie(Chinese Academy of Sciences), Li Wang(Sichuan University), Zhujuan Xiong(Sichuan Cancer Hospital), Wenxiu Yao(Sichuan Cancer Hospital)
Cited by 43
Related Papers
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Oncology|2022|417
The CspA family in <i>Escherichia coli</i> : multiple gene duplication for stress adaptation
|Molecular Microbiology|1998|342
Gene Expression Profiling of Cells, Tissues, and Developmental Stages of the Nematode C. elegans
|Cold Spring Harbor Symposia on Quantitative Biology|2003|319
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311